We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 118

UK Patents Court judgment in Laboratorios Almirall SA v Boehringer Ingelheim International GmbH
  • Bird & Bird
  • United Kingdom
  • March 11 2009

This case concerned a tit-for-tat revocation of two patents claiming the combinations of a particular anticholinergic with -agonists for treating respiratory illnesses


Preliminary injunctions in pharmaceutical patent actions
  • Bird & Bird
  • Italy
  • May 13 2009

By a decision of 15 April 2009 issued in a preliminary injunction proceeding, the Court of Milan held that the mere grant of a Marketing Authorisation (MA) for a generic pharmaceutical product does not constitute an imminent threat of patent infringement


Patent decisions on patents for chiral compounds
  • Bird & Bird
  • United Kingdom
  • May 13 2009

A chiral compound is one which has at least one asymmetric carbon centre


Recent judgments from the English court on obviousness
  • Bird & Bird
  • United Kingdom
  • December 15 2009

On 17 November 2009, the Court of Appeal handed down its judgment in Leo Pharma v Sandoz


The Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH
  • Bird & Bird
  • Austria
  • March 11 2009

Following a reference from the Austrian Supreme Court, the ECJ ruled on two questions relating to the conditions applicable to repackaging of pharmaceutical products in a parallel imports case


Corevalve Inc. v. Edwards Lifesciences AG & Edwards Lifesciences PVT, Inc
  • Bird & Bird
  • United Kingdom
  • March 11 2009

Edwards Lifesciences, the world leader in replacement heart valves, succeeded in upholding the validity of their patent for a transcatheter valve


UK Patents Court judgment in Dr Reddy’s Laboratories v Eli Lilly
  • Bird & Bird
  • United Kingdom
  • December 31 2008

In a judgment handed down in October of this year, the Patents Court (Mr Justice Floyd) upheld EP (UK) 0,454,436 (the “Patent”) which is owned by Eli Lilly and which protects the schizophrenia drug olanzapine


Court of Appeal decides “settled” EPO case law trumps UK precedent on Swiss-type claim to a new dosage regime
  • Bird & Bird
  • United Kingdom
  • July 16 2008

The Court of Appeal has decided in the case of Actavis UK Ltd v Merck & Co Inc 2008 EWCA Civ 444, that a Swiss-type claim can be patentable where the novelty is only conferred by a new dosage regime or form of administration of a substance


Paedriatric SPC extension: zero or negative term SPCs
  • Bird & Bird
  • European Union, United Kingdom
  • March 11 2009

Zero or negative term SPCs give rise to a unique disunity amongst the granting authorities in the European Member States


Status of the insufficiencyobviousness squeeze - an appraisal of the House of Lords’ Generics et al v Lundbeck judgments
  • Bird & Bird
  • United Kingdom
  • May 1 2009

In February 2009 the House of Lords unanimously dismissed an appeal by a number of pharmaceutical companies against the Court of Appeal’s decision to not revoke Lundbeck’s escitalopram patent on grounds of insufficiency